Cas:77249-85-5 (+)-palisadin B manufacturer & supplier

We serve Chemical Name:(+)-palisadin B CAS:77249-85-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(+)-palisadin B

Chemical Name:(+)-palisadin B
CAS.NO:77249-85-5
Synonyms:(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin
Molecular Formula:C15H24Br2O
Molecular Weight:380.15800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:9.23000
Exact Mass:378.01900
LogP:5.07490

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin Use and application,(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin technical grade,usp/ep/jp grade.


Related News: A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. 6-Bromo-1-methyl-1H-idazole manufacturers Only four out of the eight studies showed a reduction in ‘off’ time, and the effect did not increase with an increased dose of Nouryant.” Acid Black 220 suppliers As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.” deamino-dicarba-oxytocin vendor & factory As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.”,With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris.